Table 5.
2018–2019 Comparison of Utilization Frequency of Screening Tools in Clinic
| Each frequency comparison | |||
|---|---|---|---|
| 2018 Responsea | 2019 Response | p value | |
| Tools are administered as concerns appear during developmental surveillance | < 0.0001 | ||
| Yes | 32.7% | 8.0% | |
| No | 67.3% | 92.0% | |
| Tools are administered at 9-, 18-, and 30-month visits | < 0.0001 | ||
| Yes | 41.3% | 15.0% | |
| No | 58.7% | 85.0% | |
| Tools are administered at each well visit | < 0.0001 | ||
| Yes | 56.0% | 37.3% | |
| No | 44.0% | 62.7% | |
| Tools are administered at 9-, 18-, and 30-month visits and as concerns appear during developmental surveillance | < 0.0001 | ||
| Yes | 18.0% | 35.7% | |
| No | 82.0% | 64.3% | |
| Tools are not administered in practice | Option not provided in 2018 Survey | ||
| Yes | 4.0% | ||
| No | 96.0% | ||
In 2019, respondents were instructed to select the option that best described the frequency of tool administration within their practice. aIn 2018 each pediatrician had the option to ‘select all that apply’ for the following provided responses: Tools are administered as concerns appear during developmental surveillance; Tools are administered at 9-, 18-, and 30-month visits; Tools are administered at each well visit. Respondents that selected both ‘Tools are administered as concerns appear during developmental surveillance’ and ‘Tools are administered at 9-, 18-, and 30-month visits’ were also listed within the row labeled ‘Tools are administered at 9-, 18-, and 30-month visits and as concerns appear during developmental surveillance’